OpenEvidence
Backed by
Raised $75M Series A on Feb 20, 2025
OpenEvidence is a next-generation AI platform transforming how healthcare professionals and organizations access and apply medical information. Built on cutting-edge large language models and deep clinical data, OpenEvidence enables faster, more reliable, and more personalized decision-making for clinicians and life sciences partners.
Explore similar companies to OpenEvidence
Tennr
The intelligent automation platform for healthcare ops.
Collate
Empowering life sciences development.
Optura
AI orchestration platform for healthcare.
Plenful
AI workflow platform for healthcare.
Eternal
Longevity care for athletes.
Thatch
Modern health benefits platform.
ClarityCare AI
Streamlining health insurance prior authorization.
Silna
Make care your primary focus.
Junction
Modernizing healthcare infrastructure.